Evolution of the Average Target: Exor N.V.

Evolution of the Average Target - Exor N.V.

Evolution of the Target Price: Exor N.V.

Evolution of the Target Price - Exor N.V.

Changes in Analyst Recommendations: Exor N.V.

76664dd03b8d0b8a41184fee418.Wi7nWMZnQnXn5sOCnZF5FJnt1_NvKlJ5e5MeORDL0BU.N3etKpACdCyT1fCyxOkzf9yEo5EOGAUqEuBka36ys3JtR4sNhDMQP42PqA~ad74cf7309b81f1c675ef912681ba958
03/09 AlphaValue/Baader Europe Updates EPS Forecasts for Exor on Expected Dividend Income MT
03/09 Exor: EPS upgrade (2025: +45.4%, 2026: +54.0%) Alphavalue
16/02 AlphaValue/Baader Europe Adjusts Exor Earnings Estimates After Stellantis' Preliminary H2 2025 Results MT
14/02 Exor: EPS cut (2025: -34.6%, 2026: -29.4%) Alphavalue
27/09/25 Exor: Exor H1 2025: Strategy still in waiting Alphavalue
17/09/25 The day the Fed resumed its rate cuts Zonebourse
02/07/25 Exor: Target upgrade by 17.8% Alphavalue
28/03/25 Exor: Exor's strategic moves: Market lagging behind Alphavalue
26/03/25 BNP Paribas Exane Upgrades Exor to Outperform MT
03/12/24 Exor: Adjustments following Exor's reclassification as an Investment Entity Alphavalue
03/12/24 Exor: Stellantis' woes likely to spill over to Exor Alphavalue
02/10/24 KBC Securities Starts Exor at Buy MT
26/09/24 Exor: NAV progresses further Alphavalue
23/07/24 AlphaValue/Baader Europe Upgrades Exor to Buy, Raises PT MT
23/07/24 Exor: Opinion change, from Add to Buy Alphavalue
12/04/24 Exor: Stellantis and Ferrari continue to push Exor forward Alphavalue
05/03/24 Exor: Exor is adept for recovery bets Alphavalue
20/02/24 Exor: NAV cut by -8.8% Alphavalue
01/12/23 Exor : Exor reiterates its faith in Philips Alphavalue
15/09/23 Exor : Exor pushes the throttle Alphavalue
17/08/23 Exor : Exor delivers on its diversification strategy Alphavalue
04/07/23 Exor : EPS upgrade (2022: -20.5%, 2023: +13.5%) Alphavalue
30/05/23 Analysts recommendations: Alliant Energy, Coinbase, Constellation Brands, Medtronic... Zonebourse
18/04/23 Exor : 2022: Another milestone year in Exor's Equity Story Alphavalue
20/01/23 Exor : All eyes on Juventus with Exor and Stellantis potentially impacted Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+40.81%
+47.4%
+3.33%
+11.9%
+24.41%
+17.1%
+24.53%
+27.98%
+16.25%
+24.43%
Average +23.81%
Weighted average by Cap. +25.84%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
73.35EUR
Average target price
103.29EUR
Spread / Average Target
+40.81%
High Price Target
120.00EUR
Spread / Highest target
+63.60%
Low Price Target
89.00EUR
Spread / Lowest Target
+21.34%

Analyst Consensus Detail

Analyst consensus - Exor N.V.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Exor N.V.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Exor N.V.